C. Martin Bengtsson serves as the Executive Vice President and Chief Financial Officer at BALCHEM CORP, a position he has held since joining the company in 2017. With a robust background in finance and strategic management, Bengtsson has been instrumental in steering BALCHEM's financial strategies and enhancing its operational efficiencies. Prior to BALCHEM, he held the position of CFO at Cantel Medical Corp., where he played a pivotal role in driving the company's growth and financial stability. His career also includes significant stints at other notable firms such as Bausch & Lomb and Foster Wheeler, where he honed his expertise in financial planning and corporate development. At BALCHEM, Bengtsson's leadership has been marked by his ability to navigate complex financial landscapes and implement effective cost management strategies. Under his guidance, BALCHEM has seen sustained revenue growth and improved profitability, largely due to his focus on strategic acquisitions and operational excellence. Bengtsson's role extends beyond traditional CFO responsibilities; he is deeply involved in shaping the company's long-term vision and ensuring that financial strategies align with overall business objectives. His contributions have been vital in positioning BALCHEM as a leader in the specialty chemicals industry, and his strategic foresight continues to drive the company's success.